2-Butyl-5-methyl-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3,5-dihydro-imidazo[4,5-c]pyridin-4-one

ID: ALA295456

PubChem CID: 10252636

Max Phase: Preclinical

Molecular Formula: C25H25N7O

Molecular Weight: 439.52

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCc1nc2ccn(C)c(=O)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1

Standard InChI:  InChI=1S/C25H25N7O/c1-3-4-9-22-26-21-14-15-31(2)25(33)23(21)32(22)16-17-10-12-18(13-11-17)19-7-5-6-8-20(19)24-27-29-30-28-24/h5-8,10-15H,3-4,9,16H2,1-2H3,(H,27,28,29,30)

Standard InChI Key:  UJTSFCRAAJLWKT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   -0.2833    2.1458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8583    1.9583    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2833    2.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8583    2.9250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2292    1.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2083    2.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6958   -0.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4333    0.0833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8333    0.0333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6625   -0.4750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7542    2.1458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2292    3.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2083   -0.8667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2250   -0.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7542    2.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6708   -0.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3750    1.6583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5708   -0.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2292    1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0083    0.0958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0375    0.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3833    1.0583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8083    2.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9458    0.8458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9208    0.6833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3542    2.1458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3208   -1.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2000   -1.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1083    2.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7083    2.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8583   -1.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2958   -1.6875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0083    3.4833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  2  0
  4  3  1  0
  5  1  1  0
  6  2  1  0
  7 14  1  0
  8  9  2  0
  9  7  1  0
 10 13  1  0
 11  5  1  0
 12  3  1  0
 13  7  2  0
 14 16  2  0
 15 11  1  0
 16 18  1  0
 17  2  1  0
 18 20  2  0
 19  5  2  0
 20 25  1  0
 21 24  2  0
 22 17  1  0
 23  6  1  0
 24 22  1  0
 25 22  2  0
 26 11  1  0
 27 14  1  0
 28 16  1  0
 29 23  1  0
 30 29  1  0
 31 32  1  0
 32 28  2  0
 33 30  1  0
  4  6  2  0
 15 12  2  0
 21 18  1  0
 27 31  2  0
  8 10  1  0
M  END

Associated Targets(Human)

AGTR1 Tclin Angiotensin II receptor (1039 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Agtr1b Angiotensin II receptor (AT-1) type-1 (1480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 439.52Molecular Weight (Monoisotopic): 439.2121AlogP: 3.97#Rotatable Bonds: 7
Polar Surface Area: 94.28Molecular Species: ACIDHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 5.85CX Basic pKa: 1.86CX LogP: 5.03CX LogD: 3.76
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.41Np Likeness Score: -1.08

References

1. Mederski WW, Dorsch D, Bokel HH, Beier N, Lues I, Schelling P..  (1994)  Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives.,  37  (11): [PMID:8201597] [10.1021/jm00037a014]
2. Sharma MC, Kohli DV.  (2013)  A comprehensive structureactivity analysis 2,3,5-trisubstituted 4,5-dihydro-4-oxo-3H-imidazo [4,5-c] pyridine derivatives as angiotensin II receptor antagonists: using 2D- and 3D-QSAR approach,  22  (2): [10.1007/s00044-012-0040-z]

Source